AR and posterior cortical atrophy: The treatment of advanced or metastatic prostate cancer (PCa) is focussed around androgen deprivation therapy (ADT), as testosterone and dihydrotestosterone promote neoplastic behaviour of PCa cells through androgen receptor (AR) signalling.